This inventor holds 1 USPTO granted patent. Top assignees: Cmg Pharmaceutical Co., Ltd., Handok Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 5 Years Active: 2017
Title: Cheol Hwan Yoon: Innovator in Trk Inhibitors
Introduction
Cheol Hwan Yoon is a notable inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel chemical compounds.
Latest Patents
Yoon holds a patent for "Fused ring heteroaryl compounds and their use as Trk inhibitors." This patent discloses innovative chemical compounds represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer, or prodrug thereof. The compounds are designed to act as inhibitors of Trk and are useful in treating pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
Career Highlights
Throughout his career, Cheol Hwan Yoon has worked with various pharmaceutical companies, including Cmg Pharmaceutical Co., Ltd. and Handok Inc. His work has focused on developing therapeutic solutions that address critical health issues.
Collaborations
Yoon has collaborated with notable colleagues such as Moonsoo Kim and Chaewoon Lee. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Cheol Hwan Yoon's innovative work in the field of Trk inhibitors showcases his dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact on the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile